{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3454, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-0e9a-77d8-9937-7ab3209deb61", "docSlug": "f74ab85f614c59d29364ec58f4800496", "documentTitle": "Talkspace | Results Presentation Deck | 11 slides", "authorId": "talkspace", "authorName": "Talkspace", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a footnote explaining the composition of 'Financial income, net'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0e9a-77d8-9937-7ab3209deb61/11", "deckHref": "/decks/019de075-0e9a-77d8-9937-7ab3209deb61", "deckAnchorHref": "/decks/019de075-0e9a-77d8-9937-7ab3209deb61#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/09W-UlDNkx_lI8KvTFRrewIqcGRfPsZSQYLCSTDGYJg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZjViZDhiODNiMjkxMjEwMGExZWI4MmI2NjA0NmJkMC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/1", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "2a623ddd-b1c1-4c41-94fc-d06bbfb941dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The presentation starts with an agenda and key messages, grabbing the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/VQTJ55KcC91Jx17W8Q_qPEF7azTuy5tKgq1KCkC0J8A/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZjViZDhiODNiMjkxMjEwMGExZWI4MmI2NjA0NmJkMC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/NE1nzrvRKyMTlUEw-DzejQymAQW2mmhpIOlsD8aIeoc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZjViZDhiODNiMjkxMjEwMGExZWI4MmI2NjA0NmJkMC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/2NdZVLZZwQzmnbrU9niQVT1VBLRNzhNLEVT5078uoDA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZjViZDhiODNiMjkxMjEwMGExZWI4MmI2NjA0NmJkMC9wMDAxLnBuZw" }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/2", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "2a623ddd-b1c1-4c41-94fc-d06bbfb941dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The presentation starts with an agenda and key messages, grabbing the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/3", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "2a623ddd-b1c1-4c41-94fc-d06bbfb941dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The presentation starts with an agenda and key messages, grabbing the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/4", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "2a623ddd-b1c1-4c41-94fc-d06bbfb941dc", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The presentation starts with an agenda and key messages, grabbing the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" }, { "to": 4, "from": 4, "beatId": "5d053a84-4c89-4df9-af0b-fc1e37cf34f0", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Key Messages", "beatSlug": null, "evidence": "The presentation highlights key messages and 2023 targets.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "before_after", "function": "summarize", "notes": "Uses a before-after framing to show alignment between stated goals and actual performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/5", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "before_after", "function": "summarize", "notes": "Uses a before-after framing to show goal alignment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/6", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "before_after", "function": "summarize", "notes": "Uses a simple before-after framing to track progress against specific financial goals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/7", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/8", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses two bar charts to demonstrate growth in both financial and volume metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/9", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a line chart for hospital share and a combo bar/line chart for community share.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/10", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a highlighted bar for the most recent quarter (2023-Q1) to emphasize the record-high performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/11", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/12", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a before-after structure to justify a design change based on patient sub-grouping.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/13", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a clinical trial methodology including randomization, treatment duration, and primary/secondary endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/14", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 14, "from": 14, "beatId": "081ca352-5fd3-461b-810d-69c7f167aa11", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Methodology", "beatSlug": null, "evidence": "The presentation provides details on study design and methodology.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/15", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "cover", "function": "front_matter", "notes": "Includes company branding and study logo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/16", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "before_after", "function": "present_solution", "notes": "The slide uses a before-after framework to illustrate the physiological impact of the drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/17", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "before_after", "function": "frame_problem", "notes": "Uses a before-after framing to explain the mechanism of action for Ampreloxetine.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/18", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a process-flow layout to connect mechanism to clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/19", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "analyze_data", "notes": "The chart is a forest plot showing LS Mean differences with 95% confidence intervals for various OHQ questionnaire scores.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/20", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a clinical trial methodology using a randomized withdrawal design.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/21", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "comparison_table", "function": "size_opportunity", "notes": "The slide uses a combination of market sizing metrics and a competitive product comparison table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/22", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/23", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes GAAP and non-GAAP financial data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/24", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes per share data and share counts for basic and diluted calculations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/25", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide emphasizes the company's improved financial position, specifically the reduction in debt and share buybacks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/26", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/27", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/28", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "key_messages", "function": "summarize", "notes": "Uses a timeline-like arrow structure to represent progression of value drivers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/29", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "other", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/30", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "disclaimer", "function": "other", "notes": "Standard pharmaceutical product disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/31", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "other", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/32", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/33", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes definitions for COPD, nOH, and PTE in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/34", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "revenue_buildup", "function": "present_framework", "notes": "The slide uses a mathematical formula structure to explain revenue recognition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/35", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table displays projected royalties and milestones for 2023-2026, while the right side details royalty return dates for 2029 and 2031.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/36", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses two distinct colored containers to contrast the two different drug deal structures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/37", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Uses a funnel diagram to illustrate market penetration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/38", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "other", "function": "other", "notes": "Slide 39 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/39", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "before_after", "function": "present_solution", "notes": "The slide contrasts a narrow 'dizziness' focus with a broader 'constellation of symptoms' approach for MSA patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/40", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 5, "beatId": "18f97180-6c3c-4b05-a378-979222504b06", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Before-After", "beatSlug": null, "evidence": "Multiple slides show progress and growth using before-after comparisons.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0f3e-7563-9ac8-6248b1eac169", "docSlug": "df5bd8b83b2912100a1eb82b66046bd0", "documentTitle": "Theravance Biopharma | Results Presentation Deck | 41 slides", "authorId": "theravance-biopharma", "authorName": "Theravance Biopharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a three-column layout to categorize achievements into product, clinical, and financial pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0f3e-7563-9ac8-6248b1eac169/41", "deckHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169", "deckAnchorHref": "/decks/019de075-0f3e-7563-9ac8-6248b1eac169#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/4eINDiuW7RmfYFbVTakbFWlSaFS7aBbh0PZgMhMXqFM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wOGE4MGIzNGI4OTg1ODA2ZWQxNzhkOTYyYzIzNWQxYS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/1", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-1", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "109b3b83-0b4d-48e3-b3e3-a371386dcf59", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The cover slide and disclaimer provide context for the acquisition and the purpose of the presentation.", "position": 0, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/V_nMdB9S0JEmNmXxsH_KZi04vrk0YlSZ4Epl6gqh5R8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wOGE4MGIzNGI4OTg1ODA2ZWQxNzhkOTYyYzIzNWQxYS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/D5BbZLyTWtYEtOVO7IgoUoxsO4k9wu11_TPftd12_2I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wOGE4MGIzNGI4OTg1ODA2ZWQxNzhkOTYyYzIzNWQxYS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/TPjKHhxDHROKEOkboM0WHOTy47qdcSiAzEpYRUW0G0c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wOGE4MGIzNGI4OTg1ODA2ZWQxNzhkOTYyYzIzNWQxYS9wMDAxLnBuZw" }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/2", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-2", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "109b3b83-0b4d-48e3-b3e3-a371386dcf59", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The cover slide and disclaimer provide context for the acquisition and the purpose of the presentation.", "position": 0, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "appendix_disclosure", "function": "establish_context", "notes": "Standard regulatory disclosure slide detailing IFRS 3 and SEC Regulation S-X compliance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/3", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-3", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "appendix_disclosure", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/4", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-4", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a waterfall bridge to reconcile equity adjustments between two entities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/5", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-5", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 9, "from": 5, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "4ec4f368-0234-44a9-ad2d-1d3b13aa3589", "evidence": "Slides 5-9 provide financial data and calculations that help to benchmark the current situation against the expected outcome.", "position": 1, "objective": "The gap between the current financial situation and the expected outcome of the acquisition", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "fcb5f293-4a45-458d-a746-fae42ed943de", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 5-10 provide detailed financial information, including pro forma shareholders' equity estimates and fair value adjustments.", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table highlights that these adjustments are CET1 neutral.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/6", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-6", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 9, "from": 5, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "4ec4f368-0234-44a9-ad2d-1d3b13aa3589", "evidence": "Slides 5-9 provide financial data and calculations that help to benchmark the current situation against the expected outcome.", "position": 1, "objective": "The gap between the current financial situation and the expected outcome of the acquisition", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "fcb5f293-4a45-458d-a746-fae42ed943de", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 5-10 provide detailed financial information, including pro forma shareholders' equity estimates and fair value adjustments.", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a breakdown of mark-downs and mark-ups for various asset classes, including loans, real estate, and software, following IFRS 3 acquisition rules.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/7", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-7", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 9, "from": 5, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "4ec4f368-0234-44a9-ad2d-1d3b13aa3589", "evidence": "Slides 5-9 provide financial data and calculations that help to benchmark the current situation against the expected outcome.", "position": 1, "objective": "The gap between the current financial situation and the expected outcome of the acquisition", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "fcb5f293-4a45-458d-a746-fae42ed943de", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 5-10 provide detailed financial information, including pro forma shareholders' equity estimates and fair value adjustments.", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table breaks down impacts on Assets, Liabilities, Equity, and CET1 capital.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/8", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-8", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 9, "from": 5, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "4ec4f368-0234-44a9-ad2d-1d3b13aa3589", "evidence": "Slides 5-9 provide financial data and calculations that help to benchmark the current situation against the expected outcome.", "position": 1, "objective": "The gap between the current financial situation and the expected outcome of the acquisition", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "fcb5f293-4a45-458d-a746-fae42ed943de", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 5-10 provide detailed financial information, including pro forma shareholders' equity estimates and fair value adjustments.", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "The chart bridges Credit Suisse equity to pro forma negative goodwill via transaction adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/9", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-9", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 9, "from": 5, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "4ec4f368-0234-44a9-ad2d-1d3b13aa3589", "evidence": "Slides 5-9 provide financial data and calculations that help to benchmark the current situation against the expected outcome.", "position": 1, "objective": "The gap between the current financial situation and the expected outcome of the acquisition", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "fcb5f293-4a45-458d-a746-fae42ed943de", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 5-10 provide detailed financial information, including pro forma shareholders' equity estimates and fair value adjustments.", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "appendix_data", "function": "analyze_data", "notes": "This is a financial disclosure table detailing the accounting adjustments made during the Credit Suisse acquisition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/10", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-10", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "fcb5f293-4a45-458d-a746-fae42ed943de", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "Slides 5-10 provide detailed financial information, including pro forma shareholders' equity estimates and fair value adjustments.", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-0fe2-752e-98a4-3ce946bdd790", "docSlug": "08a80b34b8985806ed178d962c235d1a", "documentTitle": "UBS | Mergers and Acquisitions Presentation Deck | 11 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard regulatory filing boilerplate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-0fe2-752e-98a4-3ce946bdd790/11", "deckHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790", "deckAnchorHref": "/decks/019de075-0fe2-752e-98a4-3ce946bdd790#slide-11", "loopMatches": [ { "to": 11, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58ec4875-809e-4be7-aeb2-fe7eb68b3fd3", "evidence": "The document provides detailed financial information and regulatory disclosures, indicating a high level of transparency.", "position": 0, "objective": "The cost of not disclosing detailed financial information and regulatory compliance", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/J_P6u6iyyfZtsLEydZeuAqD8DnyqeVLv--aa5oWtKmc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDJiMWYyMGY2M2VlYmJiMGIwZjU5N2NmNDNhMmVkNC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/1", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/baBzhS_d1UjB0a6L0s9Ma44XVcbuDHj1fcNB51Y1b_Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDJiMWYyMGY2M2VlYmJiMGIwZjU5N2NmNDNhMmVkNC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/S2qD56pe3g2ll1jx1jOSYmsjDEDa12qysMRZ2t7pD5A/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDJiMWYyMGY2M2VlYmJiMGIwZjU5N2NmNDNhMmVkNC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/6sPFVA6aN69QFsNNLdQbby2qwoNg7U6Du_QmiJy0QJs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZDJiMWYyMGY2M2VlYmJiMGIwZjU5N2NmNDNhMmVkNC9wMDAxLnBuZw" }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "agenda", "function": "front_matter", "notes": "The slide features a baseball player image, likely a metaphor for 'hitting it out of the park' or performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/2", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/3", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/4", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "2cbcd128-f8bf-43d8-adb3-c14a10506a68", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The section 'Business Highlights & Updates' can be seen as an overview of the current situation", "position": 0, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a process-flow visual to connect three key financial metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/5", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-5", "loopMatches": [ { "to": 6, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6a90c10b-5423-4153-8a55-15563c597d23", "evidence": "The sections 'Q1 2023 Highlights' and 'Fan Engagement Accelerated by Our Investments' imply that not investing in fan engagement would have negative consequences", "position": 0, "objective": "What are the consequences of not investing in fan engagement?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "1ffbcd36-7e58-4d91-adbf-7ecbe8e3981a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The 'Q1 2023 Highlights' section provides an overview of key performance indicators", "position": 1, "confidence": 0.7, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "2020 data is omitted due to COVID-19 pandemic.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/6", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-6", "loopMatches": [ { "to": 6, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "6a90c10b-5423-4153-8a55-15563c597d23", "evidence": "The sections 'Q1 2023 Highlights' and 'Fan Engagement Accelerated by Our Investments' imply that not investing in fan engagement would have negative consequences", "position": 0, "objective": "What are the consequences of not investing in fan engagement?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-10a9-726a-b6b8-a5b1320b23d9", "docSlug": "cd2b1f20f63eebbb0b0f597cf43a2ed4", "documentTitle": "Vivid Seats | Results Presentation Deck | 20 slides", "authorId": "vivid-seats", "authorName": "Vivid Seats", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-10a9-726a-b6b8-a5b1320b23d9/7", "deckHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9", "deckAnchorHref": "/decks/019de075-10a9-726a-b6b8-a5b1320b23d9#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }